Publication | Closed Access

In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design

Molecular PharmacologyNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryMedicineRational Drug DesignSilico Molecular StudiesDrug DevelopmentNatural CompoundsPharmacologyMolecular ModelingDrug DiscoveryLigand-based Design